Furthermore, we found miR-223-3p inhibitor increased gene sox11 (sex determining region Y-box 11) expression and overexpression of sox11 has negative effects on ovarian cancer cell proliferation, migration, and invasion. This evidence concerns the gene SOX11 and ovarian carcinoma.